DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ shed 1.08% to $614.78 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.22% to 7,580.06 and the Dow Jones Industrial Average rising 0.72% to 51,032.46.
This was the stock's sixth consecutive day of losses.
Regeneron Pharmaceuticals Inc. closed 25.13% short of its 52-week high of $821.11, which the company achieved on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 0.09% to $336.79, Moderna Inc. (MRNA) fell 0.80% to $47.19, and Gilead Sciences Inc. (GILD) fell 1.31% to $134.43.
Data source: Dow Jones Market Data, FactSet. Data compiled May 29, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 29, 2026 16:46 ET (20:46 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.